Abrdn Life Sciences Investors (HQL) — DEF 14A Filings
All DEF 14A filings from Abrdn Life Sciences Investors. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
abrdn Life Sciences Investors DEF 14A Filing
— Apr 14, 2025 Risk: low
abrdn Life Sciences Investors (formerly Tekla World Healthcare Fund) filed a DEF 14A on April 14, 2025, for the period ending May 28, 2025. The filing pertains -
abrdn Life Sciences Investors Announces Annual Meeting of Shareholders
— Apr 22, 2024 Risk: low
abrdn Life Sciences Investors (HQL) filed a Proxy Statement (DEF 14A) with the SEC on April 22, 2024. Annual meeting of shareholders for abrdn Life Sciences Inv
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX